Cormorant Asset Management, LP Edgewise Therapeutics, Inc. Transaction History
Cormorant Asset Management, LP
- $943 Million
- Q1 2025
A detailed history of Cormorant Asset Management, LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 4,101,992 shares of EWTX stock, worth $60.3 Million. This represents 9.57% of its overall portfolio holdings.
Number of Shares
4,101,992
Previous 3,406,534
20.42%
Holding current value
$60.3 Million
Previous $91 Million
0.78%
% of portfolio
9.57%
Previous 7.18%
Shares
12 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$221 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$131 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$96.3 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$90.6 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$88.5 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $929M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...